CAJ | 학술논문

目的：探讨辅舒酮气雾剂联合孟鲁司特治疗支气管哮喘的临床疗效；方法选择60例支气管哮喘患者随机分为两组，对照组和治疗组各30例，对照组予吸氧、抗炎、扩张支气管、全身糖皮质激素等常规基础治疗，治疗组在对照组的基础上吸入辅舒酮气雾剂联合口服孟鲁司特咀嚼片治疗，14天为一个疗程，一个疗程后比较两组患者的临床疗效、肺功能变化。结果治疗组临床总有效率为90%，高于对照组总有效率66.7%，两组疗效经Ridit分析，治疗组明显优于对照组（U=2.2733，p<0.05），治疗期间两组均未出现明显不良反应。结论在常规治疗的基础上吸入辅舒酮气雾剂联合孟鲁司特治疗支气管哮喘方法疗效佳，值得在临床上广泛推广。
목적：탐토보서동기무제연합맹로사특치료지기관효천적림상료효；방법선택60례지기관효천환자수궤분위량조，대조조화치료조각30례，대조조여흡양、항염、확장지기관、전신당피질격소등상규기출치료，치료조재대조조적기출상흡입보서동기무제연합구복맹로사특저작편치료，14천위일개료정，일개료정후비교량조환자적림상료효、폐공능변화。결과치료조림상총유효솔위90%，고우대조조총유효솔66.7%，량조료효경Ridit분석，치료조명현우우대조조（U=2.2733，p<0.05），치료기간량조균미출현명현불량반응。결론재상규치료적기출상흡입보서동기무제연합맹로사특치료지기관효천방법료효가，치득재림상상엄범추엄。
Objective To investigate the clinical efficacy of the treatment with flixotide aerosol combination montelukast for Bronchial Asthma. Methods 60 patients with Bronchial Asthma were randomly divided into 2 groups, control group & treatment group each 30 cases. Control group used conventional basic treatment, like oxygen, anti-inflammatory, bronchial expansion, and the systemic glucocorticoid treatment, and treatment group was also in the conventional way, moreover, plus the treatment of flixotide aerosol and oral montelukast chewable tablets. 14 days for a course of treatment, after a course of treatment, the two groups were compared in the efficacy and lung function changes. Results The total effective rate in the treatment group was 90%, higher than that of the control group total effectiveness 66.7%, two groups of curative effect by Ridit analysis, the treatment group was significantly better than the control group (U=2.2733, p<0.05), treatment during the two groups had no obvious adverse reaction. Conclusion It is much better to use the conventional treatment then plus the treatment of flixotide aerosol and montelukast for Bronchial Asthma, thus it is worth promoting in clinical.